IHC staining of the tumour sections confirmed the lower expression level of UGDH in the UGDH knockdown group compared to in the control group (Figure 5E), indicating the long‐term inhibition via shRNA in our injected cells. The gene discussed is UGDH; the disease is neoplasm.